[Determination of the dose-response curve of a new hypolipidemic molecule: tibric acid (CP-18524). Methodologic and statistical aspects].
D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use*
D000960:Hypolipidemic Agents; D010880:Piperidines
Détermination de la courbe dose-effet d'une nouvelle molécule hypolipidémiante: l'acide tibrique (CP-18524). Aspects méthodologiques et statistiques